Showing 65,281 - 65,300 results of 103,304 for search '(( 5 ((((mean decrease) OR (we decrease))) OR (a decrease)) ) OR ( 2 step decrease ))', query time: 1.50s Refine Results
  1. 65281

    Dysregulation of Cyclin B-associated proteins with loss of FlnB function. by Jianjun Hu (19574)

    Published 2014
    “…<p>(A) Flow cytometry following propridium iodide (PI) labeling demonstrates a decrease in the number of FlnBsh2 chondrocytes that reside in G2/M phase and an increase in the number of cells that reside in G1/G0 phase, compared to ATDC5 control cells. …”
  2. 65282

    Supplementary Material for: Nephrologist Interventions to Avoid Kidney Replacement Therapy in Acute Kidney Injury by Chávez-Íñiguez J.S. (11189730)

    Published 2021
    “…<b><i>Results:</i></b> From 2017 to 2020, we analyzed 288 AKI patients. The mean age was 55.3 years, 60.7% were male, AKI KDIGO stage 3 was present in 50.5% of them, sepsis was the main etiology 50.3%, and 72 (25%) patients started KRT. …”
  3. 65283

    Data_Sheet_1_Combined Carbon and Albedo Climate Forcing From Pine and Switchgrass Grown for Bioenergy.pdf by Benjamin J. Ahlswede (12539725)

    Published 2022
    “…We found that pine had a net positive radiative forcing (warming) of 5.4 ± 2.8 Wm<sup>−2</sup> when albedo and carbon were combined together (30 year mean). …”
  4. 65284

    Subtropical high-montane forest climate refuges in Brazil by Guilherme Neto dos Santos (6721397)

    Published 2023
    “…The potential area of Crinodendron brasilense Reitz & L.B.Sm. decreased the most, by 82.11 % (RCP 4.5) and 90.06 % (RCP 8.5), respectively. …”
  5. 65285

    Reaching endpoints for lymphatic filariasis elimination- results from mass drug administration and nocturnal blood surveys, South Gujarat, India by Anjali Modi (3900520)

    Published 2017
    “…The current strategy to interrupt transmission of LF, is administration of once-yearly, single-dose, two-drug regimen (Albendazole with Diethylcarbamazine (DEC) to be used in endemic areas with the goal of reaching 65% epidemiological coverage for 4–6 years. We report findings of independent assessment from year 2010 to 2015 for last six rounds, after initial five rounds of Mass Drug Administration (MDA) since 2005 for ELF in endemic area of Gujarat.…”
  6. 65286

    Table_1_Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis.pdf by Tatjana Welzel (11753417)

    Published 2021
    “…Colchicine was started at 0.5–1.0 mg/day. DA was captured by physician (PGA) and patient/parent (PPGA) global assessment on a 10 cm visual analog scale, categorized as mild (<2), moderate (2–4), and high (≥5). …”
  7. 65287

    The CCDC66 depletion disrupts endocytosis and membrane recycling near cilia. by Jovana Deretic (13113617)

    Published 2025
    “…<b>(B)</b> Measured is the mean pixel intensity of a circular 5 μm<sup>2</sup> area centered at the ciliary base of each cell in <b>(A)</b>. …”
  8. 65288

    Subaortic Membrane Resection and Septal Myectomy by Amr Alsalakawy (17888560)

    Published 2024
    “…</p><p dir="ltr">Although an adjuvant septal myectomy is currently still controversial, it is sometimes considered fundamental because it helps to relieve the subvalvular LVOTO and decrease the incidence of recurrence of the SAM (2).…”
  9. 65289

    AS101 prevents renal hypertrophy in STZ injected rats. by Itay Israel Shemesh (669254)

    Published 2014
    “…*p<0.01 increase vs. control group. #p<0.01 decrease vs. STZ+PBS group (n = 5 for Control; n = 7 for STZ+PBS; n = 9 for STZ+AS101 LD; n = 8 for STZ+AS101 HD).…”
  10. 65290

    Effects of CANA on metabolites evaluated by metabolomics. by Dan Nakano (8775380)

    Published 2020
    “…Red circle indicates differential metabolites, which determined the condition of >1.5-fold increase with P<0.05 or <0.7-fold decrease with P<0.05. …”
  11. 65291

    Effectiveness of all intervention scenarios. by Yae Jee Baek (9565342)

    Published 2020
    “…We assume the sensitivity of front door screening of 0.5 or 0.7 and the protection rates possibly becoming 0.3, 0.6, or 0.9 as reinforcing protection device. …”
  12. 65292

    Effectiveness of all intervention scenarios. by Yae Jee Baek (9565342)

    Published 2021
    “…We assume the sensitivity of front door screening of 0.5 or 0.7 and the protection rates possibly becoming 0.3, 0.6, or 0.9 as reinforcing protection device. …”
  13. 65293

    PIN1 endocytosis is inhibited in the lobe region by the ROP2 pathway in PCs. by Shingo Nagawa (173932)

    Published 2012
    “…Coexpressing CA-ROP2 suppressed both vesicle formation and decrease of PM signal in <i>rop4 R2i</i> cells (<i>n</i> = 5). …”
  14. 65294

    Effect of siRNA specific for PIASy and E12 in α-SMA regulation in MCs. by Kazuo Torikoshi (150022)

    Published 2012
    “…<p>(A) PIASy mRNA and protein were reduced by transfection of siRNA against PIASy in mouse MCs. …”
  15. 65295

    Data_Sheet_1_Molecular epidemiological characteristics of Mycobacterium leprae in highly endemic areas of China during the COVID-19 epidemic.docx by Jiaojiao Zhou (432827)

    Published 2024
    “…</p>Results<p>There was an 18.97% decrease in the number of counties and districts reporting cases. …”
  16. 65296

    <sup>1</sup>H NMR in Solution and Solid State Structural Study of Lanthanide(III) Cryptates by C. Platas (2978436)

    Published 1999
    “…We present here a detailed structural comparison, both in the solid state and in aqueous solution, of a complete series of lanthanide cryptate complexes of a Schiff base axial macrobicyclic ligand L of general formula [LnL][NO<sub>3</sub>]<sub>3</sub>·<i>x</i>H<sub>2</sub>O (Ln = La−Lu, Y); the macrobicyclic receptor L is an azacryptand N[(CH<sub>2</sub>)<sub>2</sub>NCH−R−CHN(CH<sub>2</sub>)<sub>2</sub>]<sub>3</sub>N (R = <i>m</i>-C<sub>6</sub>H<sub>2</sub>OH-2-Me-5). …”
  17. 65297

    DataSheet_1_Nationwide Trends of Pediatric Obesity and BMI z-Score From 2017-2021 in China: Comparable Findings From Real-World Mobile- and Hospital-Based Data.docx by Yan Yang (33204)

    Published 2022
    “…The trend of obesity prevalence remained stable with slight decrease, but COVID-19 lockdown caused a significant increase of 1.86% in 2020. …”
  18. 65298

    Mutations at p53 binding sites augment PIK3CA promoter activity. by Snehal M. Gaikwad (279479)

    Published 2013
    “…Representative bioluminescent images of the mice bearing tumors of A2780-MPFT3 cells. Mouse from control and treated group exhibited specific [Fig. 5e3 (pre-treatment)] signals which did not decrease even after two treatments of cisplatin [Fig. 5e3 (post-treatment)].…”
  19. 65299

    Table1_Effect of botanical drugs in improving symptoms of hypertensive nephropathy: Analysis of real-world data, retrospective cohort, network, and experimental assessment.XLSX by Jia-Ming Huan (15185389)

    Published 2023
    “…</p><p>Results: A total of 14 botanical drugs and five symptom communities were obtained from real-world clinical data. …”
  20. 65300

    Image_1_Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infa... by Yang Xiao (146335)

    Published 2021
    “…., opiates, benzodiazepines, P2Y<sub>12</sub> antagonist, propofol) need to be identified in preclinical models.</p><p>Methods: Here, we examined the efficacy of promising cardioprotective compounds [fingolimod (Fingo), empagliflozin (Empa), melatonin (Mela) and nicotinamide riboside (NR)] administered i.v. as bolus before start ischemia. …”